Molecule Details
| InChIKey | ULNKQNZHAYJFGP-UHFFFAOYSA-N |
|---|---|
| Compound Name | [3-[[2-methyl-3-(trifluoromethyl)phenyl]methyl]-6-morpholin-4-yl-8-(1H-pyrazol-5-yl)imidazo[1,2-b]pyridazin-2-yl]methanol |
| Canonical SMILES | Cc1c(Cc2c(CO)nc3c(-c4ccn[nH]4)cc(N4CCOCC4)nn23)cccc1C(F)(F)F |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 4 |
| Pfam Stratification | Homologous |
| Avg pChEMBL | 6.91 |
| Source | ChEMBL;BindingDB |
2D Structure
Activity Profile
Target Activities (4)
| Target | Gene | Organism | Category | Pfam | pChEMBL | Type | Source |
|---|---|---|---|---|---|---|---|
| O00750 | PIK3C2B | Homo sapiens | Human | PF00168 PF00454 PF00792 PF00794 PF00613 PF00787 | 8.1 | Kd | ChEMBL;BindingDB |
| P42345 | MTOR | Homo sapiens | Human | PF02259 PF02260 PF08771 PF23593 PF11865 PF00454 | 6.8 | Kd | ChEMBL;BindingDB |
| O00329 | PIK3CD | Homo sapiens | Human | PF00454 PF00792 PF02192 PF00794 PF00613 | 6.6 | Kd | ChEMBL;BindingDB |
| P48736 | PIK3CG | Homo sapiens | Human | PF00454 PF00792 PF00794 PF00613 PF19710 | 6.2 | Kd | ChEMBL;BindingDB |